Fully Compliant

Regulatory Status & Product Scope

Three Leg Horse currently operates as a research and development initiative focused on flavor innovation and regulatory compliance pathways. Stallion Elixir is presently offered as a zero-proof roots tonic only. No alcoholic beverages are currently produced, sold, or offered for pre-order.

Any references to future full-proof products are purely aspirational research goals and do not constitute commercial offerings, pre-orders, or guarantees of future availability. All alcohol production remains contingent upon successful completion of federal TTB approval processes, state licensing requirements, and comprehensive regulatory compliance reviews.

• Current Product: Zero-proof roots tonic (Stallion Elixir) only.
• Future Products: Alcohol production deferred pending TTB and local licensing completion.
• No Securities: No tokens, NFTs, or digital asset fundraising mechanisms are active or planned.
• R&D Focus: Treasury contributions fund research, compliance preparation, and transparency reporting only.
• Regulatory Uncertainty: All future product timelines subject to regulatory approval durations beyond our control.

Treasury Use & Non-Investment Notice

IMPORTANT: Contributions to Three Leg Horse treasury are not investments, securities, or financial products of any kind. They do not provide ownership stakes, equity positions, profit rights, voting privileges, or any expectation of financial return. Contributors receive no ownership interest in Three Leg Horse, its assets, intellectual property, or future revenue streams.

Treasury funds are allocated exclusively to documented research activities, technical infrastructure development, regulatory preparation costs, and public transparency reporting. No representations, warranties, or implications of financial return, appreciation, or investment opportunity are made.

• No Investment: Contributions are donations with zero expectation of return.
• No Ownership: Contributors receive no equity, tokens, shares, or ownership rights.
• No Returns: No dividends, yield distributions, profit shares, or revenue distributions will ever be paid.
• Irreversible: All blockchain transfers are final and cannot be reversed or refunded.
• Transparent Use: Detailed expenditure reports published for public accountability.

Refund & Cancellation Policy

Given the current non-commercial research scope, there are no product transactions to refund. Should the initiative discontinue prior to any regulated launch, a discretionary pro-rata allocation of remaining fiat reserves (if any) may be evaluated subject to legal advice; blockchain transfers cannot be reversed.

Terms of Use (Summary)

• Participation is voluntary and does not create partnership, joint venture, or agency.
• Intellectual property (formulas, branding, content) remains exclusively owned by Three Leg Horse.
• All forward-looking statements are subject to regulatory, technical, and market uncertainties.
• No warranty is provided regarding uninterrupted access or future product availability.
• Jurisdiction: Applicable regulatory regimes of relevant US federal agencies and other competent authorities.
• Limitation of liability applies to indirect, incidental, consequential damages to the fullest extent permitted by law.

Data & Privacy

At this stage, data collection is intentionally minimized. Should contact or contribution tooling expand, any collected personal information (name, email, optional wallet label) will be processed under a future comprehensive Privacy Policy aligned with GDPR and applicable data protection laws. Public blockchain addresses are inherently observable and not treated as confidential data.

Governance & Oversight

Formal governance mechanisms (audit committee, compliance review, external advisory) will be instituted prior to any regulated product launch. Interim treasury management will utilize multisig controls, segregation of duties for approvals, and scheduled reporting cadences.

• Planned multisig deployment with defined signer matrix.
• Quarterly transparency and expenditure summaries.
• Independent compliance counsel engagement before commercialization.

Forward-Looking Statements

Any statements regarding projected timelines, regulatory approvals, product profiles, market adoption, or treasury targets constitute forward-looking statements based on current assumptions and are subject to change without notice. Actual outcomes may differ materially due to regulatory review durations, resource availability, technological constraints, or market conditions.